ArticleGenome medicine2026
Blood cell composition reveals distinct biological interpretation of DNA methylation age and age acceleration.
Article in Genome medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundEpigenetic clocks are widely applied biomarkers of biological age, but their biological underpinnings remain unclear. We previously showed that epigenetic clocks are affected by naïve and memory T cell proportions, suggesting blood cell composition as a potential driver. However, analysis of cell composition is complicated by collinearity between cell fractions.
methodsWe first develop a principal component analysis (PCA) method that is robust to collinearity of blood cell counts and show that this approach provides biologically meaningful insights. Next, we quantify the contribution of cell composition to DNA methylation age and age acceleration estimated by six 1st - or 2nd -generation epigenetic clocks in an analysis of 4,058 samples. Finally, we test the influence of cell composition on the association between age acceleration and 176 incident health outcomes using a study of 18,859 individuals.
resultsWe find that up to 53% of the variation in DNA methylation age can be attributed to cell counts, with a particularly strong contribution of the balance between naïve and memory T cells. Associations between age acceleration and cell counts are weaker (up to 21% variance explained) and, for 2nd -generation clocks, primarily involve neutrophils. We validate the contribution of cell counts to epigenetic clocks using artificial cell mixtures. Interestingly, cell composition significantly attenuates the association of age acceleration investigated with 176 incident health outcomes, although this effect remains modest.
conclusionsDNAmAge and AgeAccel are markedly different in their associations with cell composition, indicating that they - at least in part - reflect different biological processes. Surprisingly, the variation in age acceleration that can be attributed to blood cell composition only has a minor contribution to its association with mortality and incident disease outcomes.
Indexed as
Identifiers
42823742What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.